SEOM clinical guideline in nasopharynx cancer (2017)
Clin. transl. oncol. (Print)
; 20(1): 84-88, ene. 2018. tab
Article
in En
| IBECS
| ID: ibc-170471
Responsible library:
ES1.1
Localization: BNCS
ABSTRACT
Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiation therapy is an essential component of curative-intent of non-disseminated disease and the association of chemotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy and patients may achieve a long survival time (AU)
RESUMEN
No disponible
Full text:
1
Collection:
06-national
/
ES
Database:
IBECS
Main subject:
Carcinoma, Squamous Cell
/
Nasopharyngeal Neoplasms
Type of study:
Etiology_studies
/
Guideline
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Clin. transl. oncol. (Print)
Year:
2018
Document type:
Article